StonvexLoading…
StonvexCore line items from MXL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $166.32M | $137.19M | $467.64M | $331.20M | $204.75M |
Operating Income | Not available | $-17.21M | $-126.89M | $-112.00M | $-70.71M |
Net Income | Not available | $-45.14M | $-136.68M | $-121.78M | $-26.59M |
EPS (Diluted) | $0.33 | $-0.52 | $-1.58 | $-1.41 | $-0.89 |
Total Assets | Not available | $771.27M | $796.40M | $808.13M | $863.74M |
Total Liabilities | Not available | $317.08M | $344.50M | $343.41M | $375.41M |
Cash & Equivalents | Not available | $61.08M | $72.81M | $111.86M | $108.62M |
Free Cash Flow OCF − CapEx | Not available | $-10.26M | $7.02M | $323.00K | $-4.07M |
Shares Outstanding | Not available | 89.53M | 86.45M | 87.37M | 86.91M |